Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 76 | 2024 | 5644 | 7.860 |
Why?
|
Anemia, Sickle Cell | 24 | 2024 | 1056 | 4.740 |
Why?
|
Graft vs Host Disease | 29 | 2024 | 3023 | 2.550 |
Why?
|
Fetal Hemoglobin | 9 | 2024 | 342 | 1.940 |
Why?
|
beta-Thalassemia | 5 | 2024 | 235 | 1.730 |
Why?
|
Homosexuality, Male | 13 | 2024 | 1269 | 1.720 |
Why?
|
Transplantation Conditioning | 19 | 2024 | 1593 | 1.680 |
Why?
|
Leukemia, Myeloid, Acute | 15 | 2024 | 3606 | 1.580 |
Why?
|
Sexual Partners | 7 | 2020 | 750 | 1.540 |
Why?
|
Transplantation, Homologous | 25 | 2024 | 4814 | 1.260 |
Why?
|
Hemophilia B | 2 | 2020 | 84 | 1.210 |
Why?
|
Heterocyclic Compounds | 4 | 2022 | 247 | 1.130 |
Why?
|
Hematopoietic Stem Cells | 9 | 2024 | 3390 | 1.080 |
Why?
|
Sexual Behavior | 7 | 2022 | 2080 | 1.020 |
Why?
|
Hemophilia A | 2 | 2020 | 360 | 0.980 |
Why?
|
Blood Component Removal | 2 | 2022 | 132 | 0.940 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1899 | 0.920 |
Why?
|
HLA Antigens | 3 | 2024 | 1369 | 0.810 |
Why?
|
Stereotaxic Techniques | 1 | 2024 | 549 | 0.780 |
Why?
|
Transplants | 1 | 2023 | 206 | 0.740 |
Why?
|
Dyskeratosis Congenita | 1 | 2021 | 73 | 0.720 |
Why?
|
Isoantibodies | 1 | 2024 | 661 | 0.710 |
Why?
|
Electrodes, Implanted | 1 | 2024 | 833 | 0.670 |
Why?
|
Hepatitis, Autoimmune | 1 | 2021 | 172 | 0.650 |
Why?
|
Negotiating | 1 | 2020 | 148 | 0.630 |
Why?
|
HIV Infections | 13 | 2024 | 17159 | 0.620 |
Why?
|
Gonorrhea | 1 | 2022 | 342 | 0.610 |
Why?
|
Tetany | 1 | 2017 | 13 | 0.610 |
Why?
|
Fibrosis | 2 | 2024 | 2042 | 0.600 |
Why?
|
Plasma Cells | 1 | 2021 | 592 | 0.600 |
Why?
|
Splenectomy | 1 | 2019 | 391 | 0.600 |
Why?
|
Sexually Transmitted Diseases | 2 | 2022 | 628 | 0.580 |
Why?
|
Bone Marrow | 7 | 2023 | 2918 | 0.570 |
Why?
|
Tissue and Organ Harvesting | 1 | 2020 | 377 | 0.550 |
Why?
|
Self Care | 3 | 2019 | 793 | 0.550 |
Why?
|
Organ Preservation | 1 | 2020 | 379 | 0.540 |
Why?
|
Immunocompromised Host | 1 | 2021 | 857 | 0.530 |
Why?
|
Hypocalcemia | 1 | 2017 | 199 | 0.530 |
Why?
|
Humans | 124 | 2024 | 760261 | 0.520 |
Why?
|
Child | 40 | 2024 | 79758 | 0.510 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 2696 | 0.510 |
Why?
|
Antigens, CD34 | 8 | 2024 | 652 | 0.510 |
Why?
|
Trust | 1 | 2020 | 528 | 0.490 |
Why?
|
Lung Transplantation | 2 | 2024 | 1304 | 0.470 |
Why?
|
Blood Transfusion | 2 | 2019 | 1328 | 0.470 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1401 | 0.460 |
Why?
|
Erythrocytes | 1 | 2023 | 2415 | 0.460 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2024 | 1539 | 0.450 |
Why?
|
Neuroblastoma | 2 | 2023 | 1252 | 0.450 |
Why?
|
Physicians | 2 | 2024 | 4590 | 0.440 |
Why?
|
AIDS Serodiagnosis | 3 | 2020 | 216 | 0.440 |
Why?
|
Young Adult | 28 | 2024 | 58673 | 0.400 |
Why?
|
Recurrence | 12 | 2024 | 8487 | 0.390 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 944 | 0.390 |
Why?
|
Adolescent | 30 | 2024 | 87747 | 0.390 |
Why?
|
Patient Preference | 1 | 2019 | 921 | 0.380 |
Why?
|
Aviation | 1 | 2011 | 49 | 0.380 |
Why?
|
Social Support | 2 | 2020 | 2145 | 0.360 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2023 | 265 | 0.360 |
Why?
|
Preventive Health Services | 1 | 2015 | 571 | 0.340 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1601 | 0.320 |
Why?
|
Hypoglycemia | 1 | 2016 | 888 | 0.320 |
Why?
|
gamma-Globins | 4 | 2024 | 96 | 0.320 |
Why?
|
Electroencephalography | 1 | 2024 | 6182 | 0.310 |
Why?
|
Tissue Donors | 5 | 2024 | 2314 | 0.310 |
Why?
|
Adult | 41 | 2024 | 219847 | 0.310 |
Why?
|
Statistics as Topic | 1 | 2015 | 2363 | 0.310 |
Why?
|
Mass Screening | 5 | 2020 | 5422 | 0.310 |
Why?
|
Survivors | 7 | 2024 | 2367 | 0.300 |
Why?
|
Transplantation, Autologous | 4 | 2023 | 2120 | 0.300 |
Why?
|
Male | 45 | 2024 | 359413 | 0.290 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5396 | 0.290 |
Why?
|
Laparoscopy | 1 | 2019 | 2155 | 0.290 |
Why?
|
Quality of Life | 7 | 2022 | 13300 | 0.290 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2022 | 225 | 0.270 |
Why?
|
Benzylamines | 3 | 2022 | 248 | 0.270 |
Why?
|
Heart Transplantation | 1 | 2020 | 3217 | 0.260 |
Why?
|
Child, Preschool | 12 | 2024 | 42034 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9196 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7468 | 0.250 |
Why?
|
United States | 17 | 2024 | 72363 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3421 | 0.240 |
Why?
|
Retrospective Studies | 21 | 2024 | 80301 | 0.230 |
Why?
|
Pneumocystis carinii | 1 | 2024 | 72 | 0.230 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3149 | 0.220 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 113 | 0.220 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 311 | 0.210 |
Why?
|
Hydroxyurea | 1 | 2024 | 283 | 0.210 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1442 | 0.210 |
Why?
|
Fiducial Markers | 1 | 2024 | 132 | 0.210 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2024 | 245 | 0.210 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 717 | 0.200 |
Why?
|
Leukapheresis | 1 | 2022 | 134 | 0.200 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 143 | 0.200 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2024 | 305 | 0.200 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1945 | 0.190 |
Why?
|
Graft Survival | 3 | 2022 | 3793 | 0.190 |
Why?
|
Thrombotic Microangiopathies | 1 | 2022 | 124 | 0.190 |
Why?
|
Serologic Tests | 2 | 2020 | 383 | 0.190 |
Why?
|
Female | 31 | 2024 | 391011 | 0.180 |
Why?
|
beta-Globins | 1 | 2021 | 108 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9274 | 0.180 |
Why?
|
Burkitt Lymphoma | 1 | 2022 | 333 | 0.180 |
Why?
|
Mycoses | 1 | 2023 | 387 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2023 | 248 | 0.170 |
Why?
|
Community Health Planning | 1 | 2020 | 165 | 0.170 |
Why?
|
Hematology | 1 | 2023 | 241 | 0.170 |
Why?
|
Advisory Committees | 1 | 2024 | 789 | 0.170 |
Why?
|
Neoplasms | 7 | 2024 | 22066 | 0.170 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1927 | 0.170 |
Why?
|
Prognosis | 5 | 2024 | 29636 | 0.170 |
Why?
|
Telemedicine | 2 | 2020 | 3005 | 0.160 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2220 | 0.160 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 343 | 0.160 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1387 | 0.160 |
Why?
|
Primary Graft Dysfunction | 1 | 2020 | 111 | 0.160 |
Why?
|
Research Design | 1 | 2015 | 6181 | 0.160 |
Why?
|
Reference Standards | 1 | 2022 | 1004 | 0.160 |
Why?
|
Nucleotides | 1 | 2021 | 450 | 0.160 |
Why?
|
Infertility | 2 | 2024 | 655 | 0.160 |
Why?
|
Disease-Free Survival | 4 | 2024 | 6830 | 0.150 |
Why?
|
Memory, Short-Term | 1 | 2024 | 977 | 0.150 |
Why?
|
Career Choice | 1 | 2024 | 755 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 266 | 0.150 |
Why?
|
Tacrolimus | 1 | 2021 | 730 | 0.150 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5784 | 0.150 |
Why?
|
Myeloproliferative Disorders | 1 | 2023 | 612 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 789 | 0.140 |
Why?
|
Chromosome Aberrations | 1 | 2024 | 1767 | 0.140 |
Why?
|
Fatty Liver | 1 | 2023 | 777 | 0.140 |
Why?
|
Survival Rate | 3 | 2021 | 12806 | 0.140 |
Why?
|
Unsafe Sex | 1 | 2018 | 213 | 0.140 |
Why?
|
Internet | 2 | 2024 | 3074 | 0.140 |
Why?
|
Acute Disease | 3 | 2023 | 7268 | 0.140 |
Why?
|
Germ Cells | 1 | 2020 | 635 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2024 | 2978 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2022 | 935 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2325 | 0.130 |
Why?
|
Adenine | 1 | 2021 | 976 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4786 | 0.130 |
Why?
|
Survival Analysis | 3 | 2023 | 10185 | 0.130 |
Why?
|
Infant | 7 | 2024 | 36030 | 0.130 |
Why?
|
Hypogonadism | 1 | 2021 | 800 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 800 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2204 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1522 | 0.120 |
Why?
|
Interferon Type I | 1 | 2018 | 559 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 917 | 0.120 |
Why?
|
Antibodies | 1 | 2022 | 2424 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 833 | 0.120 |
Why?
|
Heroin Dependence | 1 | 2015 | 172 | 0.120 |
Why?
|
Research Personnel | 1 | 2019 | 584 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2024 | 64947 | 0.110 |
Why?
|
Caregivers | 2 | 2023 | 2222 | 0.110 |
Why?
|
Middle Aged | 16 | 2024 | 220175 | 0.110 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.110 |
Why?
|
HIV Seropositivity | 1 | 2019 | 955 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2023 | 3967 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1109 | 0.110 |
Why?
|
Bisexuality | 1 | 2015 | 271 | 0.110 |
Why?
|
Informed Consent | 1 | 2019 | 1007 | 0.100 |
Why?
|
Busulfan | 2 | 2024 | 258 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3903 | 0.100 |
Why?
|
Lung Diseases | 1 | 2022 | 1915 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2011 | 101 | 0.100 |
Why?
|
Prisoners | 1 | 2015 | 310 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4688 | 0.100 |
Why?
|
Remission Induction | 3 | 2022 | 2394 | 0.090 |
Why?
|
Chronic Disease | 5 | 2024 | 9283 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 117 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2297 | 0.090 |
Why?
|
Whole-Body Irradiation | 2 | 2022 | 433 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2138 | 0.090 |
Why?
|
Indoles | 1 | 2018 | 1830 | 0.090 |
Why?
|
Risk Factors | 7 | 2024 | 74269 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1437 | 0.090 |
Why?
|
Graft Rejection | 1 | 2022 | 4423 | 0.080 |
Why?
|
Antigens, CD19 | 2 | 2022 | 414 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2695 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3267 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2510 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4637 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5790 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2621 | 0.080 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2021 | 628 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9629 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4317 | 0.070 |
Why?
|
Mice | 7 | 2023 | 81216 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3023 | 0.070 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1387 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7236 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2023 | 2730 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10530 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36247 | 0.070 |
Why?
|
Terminal Care | 1 | 2019 | 1759 | 0.070 |
Why?
|
Georgia | 2 | 2018 | 185 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1301 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12532 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4223 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15827 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25928 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11902 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10340 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3846 | 0.060 |
Why?
|
Cohort Studies | 4 | 2022 | 41317 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3924 | 0.060 |
Why?
|
Pentamidine | 1 | 2024 | 44 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1642 | 0.060 |
Why?
|
Calcium | 1 | 2017 | 5726 | 0.060 |
Why?
|
Antisickling Agents | 1 | 2024 | 72 | 0.060 |
Why?
|
Animals | 8 | 2024 | 167940 | 0.060 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18415 | 0.060 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10183 | 0.060 |
Why?
|
Survival | 1 | 2024 | 161 | 0.060 |
Why?
|
Myeloablative Agonists | 1 | 2024 | 209 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2011 | 3160 | 0.050 |
Why?
|
Complement Inactivating Agents | 1 | 2022 | 53 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5131 | 0.050 |
Why?
|
Aged | 7 | 2024 | 168995 | 0.050 |
Why?
|
Diterpenes | 1 | 2022 | 171 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6210 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18134 | 0.050 |
Why?
|
Base Pairing | 1 | 2021 | 140 | 0.050 |
Why?
|
North America | 1 | 2024 | 1282 | 0.040 |
Why?
|
Stomach | 1 | 2004 | 695 | 0.040 |
Why?
|
Donor Selection | 1 | 2022 | 228 | 0.040 |
Why?
|
Research Report | 1 | 2023 | 370 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 772 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12447 | 0.040 |
Why?
|
Hemoglobinopathies | 1 | 2019 | 96 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2024 | 642 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20484 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1006 | 0.040 |
Why?
|
Bacterial Translocation | 1 | 2018 | 73 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4416 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13629 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2019 | 602 | 0.040 |
Why?
|
Safe Sex | 1 | 2018 | 138 | 0.040 |
Why?
|
Siblings | 1 | 2022 | 825 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3723 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3433 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1234 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2024 | 7803 | 0.030 |
Why?
|
Pain | 2 | 2022 | 5066 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2023 | 1548 | 0.030 |
Why?
|
Gene Targeting | 1 | 2019 | 839 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1008 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13505 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1594 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2019 | 682 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1675 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21378 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2019 | 1493 | 0.030 |
Why?
|
Fetal Blood | 1 | 2022 | 1343 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1870 | 0.030 |
Why?
|
Gender Identity | 1 | 2020 | 699 | 0.030 |
Why?
|
Risk-Taking | 1 | 2020 | 1000 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2837 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 785 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1925 | 0.030 |
Why?
|
Sulfonamides | 1 | 2022 | 1973 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1940 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2023 | 2702 | 0.030 |
Why?
|
Mice, Congenic | 1 | 2011 | 97 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 248 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15766 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1430 | 0.020 |
Why?
|
Receptors, Interferon | 1 | 2011 | 116 | 0.020 |
Why?
|
Critical Care | 1 | 2024 | 2699 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2721 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3360 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54263 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14396 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1939 | 0.020 |
Why?
|
Models, Immunological | 1 | 2011 | 513 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5201 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4554 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39254 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12959 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24086 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5793 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3526 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3758 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9388 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2811 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2655 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15626 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22041 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9989 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8018 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14482 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8553 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12901 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7345 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9468 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12100 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5498 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1612 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12915 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9531 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3076 | 0.010 |
Why?
|
Brain | 1 | 2024 | 26912 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58947 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29950 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22025 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26168 | 0.000 |
Why?
|